HURA
TuHURA Biosciences, Inc. NASDAQ Listed Feb 22, 2013$2.13
+0.71%
vs $2.12
Mkt Cap $135.6M
52w Low $0.41
49.3% of range
52w High $3.90
50d MA $2.25
200d MA $1.83
P/E (TTM)
—
EV/EBITDA
—
P/B
4.9x
Debt/Equity
0.0x
ROE
-143.6%
P/FCF
-3.7x
RSI (14)
42.30
ATR (14)
$0.10
Beta
-0.32
50d MA
$2.25
200d MA
$1.83
Avg Volume
447.8K
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.
10500 University Center Drive · Tampa, FL 33612 · US
Data updated apr 25, 2026 2:23pm
· Source: financialmodelingprep.com